| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Dez―13 |
Ruxolitinib as Treatment for Hospitalized Patients with COVID-19 pneumonia. A phase II Trial |
Roberto Ovilla-Martínez, Aarón Molina-Jaimes, Xóchitl Cota-Rangel, Carolina Cárcoba-Tenorio, Cindy Ledesma-de la Cruz, Gregorio Ignacio-Ibarra, et al. (+5) Juan P. Álvarez-Mendoza, Felipe V. Villaseñor-Pérez, Adriana Miguel-Álvarez, Jessi Juárez-Lara, Pamela E. Báez-Islas |
| 2 |
[GO] |
2023―Sep―12 |
SARS-CoV-2 Pneumonia after Allogenic Stem Cell Transplantation Successfully Treated with JAK1/2 Inhibitor |
Roberto Ovilla-Martínez, Nishalle Ramírez-Muñiz, Andric Cuevas-Juárez, Pamela E. Báez-Islas |
| 3 |
[GO] |
2023―Jul―25 |
Problemas de salud mental entre dermatólogos latinoamericanos durante la pandemia de COVID-19 |
Ana Fresán Orellana, Jorge Ocampo-Candiani, Rebeca Robles-García, María I. Arellano-Mendoza, Roberto Arenas, Angélica Beirana-Palencia, et al. (+14) Horacio A. Cabo, Emilia N. Cohen-Sabban, Manuel del Solar, Judith Domínguez-Cherit, Félix Fich, Gastón Galimberti, Carlos Fernando Gatti, Carlos García-Rementería, José L. López-Estebaranz, Omar Lupi, Miguel Olmos-Pérez, Ricardo Pérez-Alfonzo, César J. Ramos-Cavazos, Alfredo Salmon-Demongin |
| 4 |
[GO] |
2023―Mai―08 |
Active Tuberculosis and SARS-CoV-2 Infection: Challenges and Opportunities for Developing Countries |
Stalin Isaías Cañizares Quisiguiña, Isis Izurieta, Ericka Tinoco, Ana Cristina Aguilar, Ivan Palaciosa |
| 5 |
[GO] |
2020―Sep―23 |
Methods of An Open - Label Proof - of - Concept Trial of Intravenous Valproic Acid for Severe COVID-19 |
Erwin Chiquete, Liz Toapanta-Yanchapaxi, Carlos Cantú-Brito |
| 6 |
[GO] |
2020―Sep―23 |
Suggesting Treatments for COVID-19. Beware! Expectations cannot Replace Good Science |
François Noël |
| 7 |
[GO] |
2020―Sep―23 |
Are the High Smoking Rates Related to COVID-19 Outbreaks? |
Andres F. Zuluaga, Maria A. Montoya - Giraldo, Jefferson A. Buendia |
| 8 |
[GO] |
2020―Sep―23 |
Pharmacological Aspects and Clues for the Rational Use of Chloroquine / ydroxychloroquine Facing the Therapeutic Challenges of COVID-19 Pandemic |
François Noël, Jaderson Lima |
| 9 |
[GO] |
2020―Sep―23 |
COVID-19 SARS Treatment with Ruxolitinib; Ongoing Trial and Method |
Roberto Ovilla-Martínez, Xóchitl Cota-Rangel, José Antonio de la Peña-Celaya, Pamela Elena Baez-Islas |
| 10 |
[GO] |
2020―Sep―23 |
Los tiempos COVID-19 y post-COVID-19: debemos asegurarnos de que la voz del paciente siempre sea escuchada |
Eva María Ruiz de Castilla |
| 11 |
[GO] |
2020―Sep―23 |
Current Pharmacological Therapy against COVID-19: A Latin American Perspective |
Bryan Nicolalde, Diego Añazco, Mariam Mushtaq, Ana Aguilar, Enrique Terán |
| 12 |
[GO] |
2020―Sep―23 |
Producción y difusión de conocimientos durante la epidemia de COVID-19: entre la necesidad y el pragmatismo de contar con buenos factores pronósticos |
Israel Rico-Alba |
| 13 |
[GO] |
2020―Sep―23 |
Which is the Pharmacodynamic Target to Calculate a Rational Dose against SARS-Cov-2? |
Andres F. Zuluaga, Carlos A. Rodriguez, Maria A. Montoya-Giraldo |
